Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials

Treatment with melphalan-prednisone-thalidomide improves the outcome of patients with multiple myeloma and is now considered a standard of care for patients not eligible for transplantation. However, this treatment is a major source of morbidity. A meta-analysis of data from individual patients (n=1...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Palumbo, Antonio, Waage, Anders, Hulin, Cyrille, Beksac, Meral, Zweegman, Sonja, Gay, Francesca, Gimsing, Peter, Leleu, Xavier, Wijermans, Pierre, Sucak, Gülsan, Pezzatti, Sara, Juliusson, Gunnar, Pégourié, Brigitte, Schaafsma, Martijn, Galli, Monica, Turesson, Ingemar, Kolb, Brigitte, van der Holt, Bronno, Baldi, Ileana, Rolke, Jürgen, Ciccone, Giovannino, Wetterwald, Marc, Lokhorst, Henk, Boccadoro, Mario, Rodon, Philippe, Sonneveld, Pieter
פורמט: Artigo
שפה:Inglês
יצא לאור: Ferrata Storti Foundation 2013
נושאים:
Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3533664/
https://ncbi.nlm.nih.gov/pubmed/22875621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.067058
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים